328 related articles for article (PubMed ID: 24815433)
21. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H
Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611
[TBL] [Abstract][Full Text] [Related]
22. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
23. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
Wu Y; Wei J; Ming Y; Chen Z; Yu J; Mao R; Chen H; Zhou G; Fan Y
J Cell Biochem; 2018 Sep; 119(9):7696-7706. PubMed ID: 29923223
[TBL] [Abstract][Full Text] [Related]
24. [Expression and significance of leukemia inhibitory factor in human pancreatic cancer].
Peng F; Zhou J; Sheng W; Zhang D; Dong M
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):90-5. PubMed ID: 24721346
[TBL] [Abstract][Full Text] [Related]
25. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
[TBL] [Abstract][Full Text] [Related]
26. [Correlation between Gli1 expression and clinicopathological significance in human pancreatic cancer].
Sheng WW; Dong M; Zhou JP; Liu QF; Li X; Dong Q
Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):916-21. PubMed ID: 24433772
[TBL] [Abstract][Full Text] [Related]
27. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.
Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y
Front Immunol; 2022; 13():970588. PubMed ID: 36148233
[TBL] [Abstract][Full Text] [Related]
28. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients.
Huang C; Yu W; Wang Q; Cui H; Wang Y; Zhang L; Han F; Huang T
Minerva Med; 2015 Jun; 106(3):143-9. PubMed ID: 25668599
[TBL] [Abstract][Full Text] [Related]
30. Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma.
Yu X; Lin Y; Sui W; Zou Y; Lv Z
Cancer Med; 2017 Mar; 6(3):673-680. PubMed ID: 28220683
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma.
Gao KT; Lian D
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
[TBL] [Abstract][Full Text] [Related]
32. The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1.
Huang CS; Chu J; Zhu XX; Li JH; Huang XT; Cai JP; Zhao W; Yin XY
Cancer Lett; 2018 May; 421():63-72. PubMed ID: 29458145
[TBL] [Abstract][Full Text] [Related]
33. The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma.
Lu Y; Wu M; Fu J; Sun Y; Furukawa K; Ling J; Qin X; Chiao PJ
Cell Prolif; 2020 May; 53(5):e12805. PubMed ID: 32364285
[TBL] [Abstract][Full Text] [Related]
34. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
35. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
Zhu Z; Xu Y; Du J; Tan J; Jiao H
J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
[TBL] [Abstract][Full Text] [Related]
36. The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1.
Jiang Y; Li Z; Zheng S; Chen H; Zhao X; Gao W; Bi Z; You K; Wang Y; Li W; Li L; Liu Y; Chen R
Tumour Biol; 2016 Mar; 37(3):3957-67. PubMed ID: 26482614
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract][Full Text] [Related]
38. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
[TBL] [Abstract][Full Text] [Related]
40. LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451.
Zhang Z; Chen H; Lu Y; Feng T; Sun W
Int J Oncol; 2018 Apr; 52(4):1224-1234. PubMed ID: 29532883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
